Search for: "Genentech, Inc. et al v. Amgen, Inc."
Results 1 - 11
of 11
Sorted by Relevance
|
Sort by Date
Judge Sleet Grants Amgen’s Motion to Dismiss Genetech’s Commercial Marketing Claim Without Prejudice
20 Apr 2018, 8:51 am
Sleet in Genentech, Inc. et al. v. [read post]
27 Jan 2018, 6:40 am
Sleet in Genentech, Inc. et al. v. [read post]
12 Mar 2020, 2:36 pm
Connolly in Genentech, Inc. et al. v. [read post]
14 Feb 2020, 12:00 pm
Connolly in Genentech, Inc. et al. v. [read post]
11 Jan 2024, 12:59 pm
Guidelines for Assessing Enablement in Utility Applications and Patents in View of the Supreme Court Decision in Amgen Inc. et al. v. [read post]
24 Feb 2022, 6:12 pm
Daktronics, Inc., et al., No. 21-438 (CVSG requested October 4, 2021); and Appellate Standing for IPR Challenger: Apple Inc. v. [read post]
14 Dec 2021, 9:57 am
There are two other eligibility cases pending: Yanbin Yu, et al. v. [read post]
6 Aug 2013, 8:36 am
See Southwall Tech., Inc. v. [read post]
11 May 2011, 4:54 am
Allergan, Inc. [read post]
8 Feb 2008, 7:00 pm
– Facebook’s contractual rights to users’ photos problematic: (Spicy IP)PharmaEuropean Commission probes pharmaceutical sector: (Philip Brooks),WHO Board sets course on IP, avian flu, tighter publication policy: (Intellectual Property Watch),India: The Competition Act, patents and over hyped drugs: (Part I - Spicy IP), (Part II – Spicy IP), (Part III – Spicy IP),Ignoring not the solution –… [read post]
2 May 2008, 7:00 am
: (Patent Baristas), US: How to avoid a permanent injunction: the lessons of Amgen v Hoffman-LaRoche: (Patent Docs), US: Jarvik Heart’s PTE request based on PMA shell/module submission dates flatlines; ruling on initiation of PTE ‘review period’ mirrors FDA policy for ‘fast track’ products: (FDA Law Blog) Pharma & Biotech - Products Kytril (Granisetron) – Exclusivity ‘parking’… [read post]